17-8015920-G-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BS2BA1BP4
This summary comes from the ClinGen Evidence Repository: The variant NM_000180.4(GUCY2D):c.3044-7G>T is located in intron 16. This variant is present in gnomAD v.4.1.0 at a Grpmax allele frequency of 0.04452, with 52,788 alleles / 1,177,142 total alleles in the European (non-Finnish) population, which is higher than the ClinGen LCA / eoRD VCEP BA1 threshold of >0.016 (BA1). This variant has been found in the homozygous state in >6 adult individuals in gnomAD (1363 individuals, gnomAD version 4.1.0; BS2). In addition, the splicing impact predictor SpliceAI gives a delta score of 0.04, which is below the ClinGen LCA / eoRD VCEP recommended threshold of ≥0.2 and does not strongly predict an impact on splicing (BP4). In summary, this variant meets the criteria to be classified as Benign for GUCY2D-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: BA1, BP4. (VCEP specifications version 1.0.0; date of approval 01/22/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA8366302/MONDO:0100453/167
Frequency
Consequence
NM_000180.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GUCY2D | NM_000180.4 | c.3044-7G>T | splice_region_variant, intron_variant | Intron 16 of 19 | ENST00000254854.5 | NP_000171.1 | ||
GUCY2D | XM_011523816.2 | c.3044-7G>T | splice_region_variant, intron_variant | Intron 15 of 18 | XP_011522118.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GUCY2D | ENST00000254854.5 | c.3044-7G>T | splice_region_variant, intron_variant | Intron 16 of 19 | 1 | NM_000180.4 | ENSP00000254854.4 | |||
ENSG00000279174 | ENST00000623126.1 | n.459C>A | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 | |||||
GUCY2D | ENST00000574510.1 | n.-209G>T | upstream_gene_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0281 AC: 4269AN: 152176Hom.: 97 Cov.: 33
GnomAD3 exomes AF: 0.0279 AC: 6685AN: 239362Hom.: 144 AF XY: 0.0286 AC XY: 3708AN XY: 129876
GnomAD4 exome AF: 0.0383 AC: 55744AN: 1455586Hom.: 1266 Cov.: 32 AF XY: 0.0378 AC XY: 27327AN XY: 723614
GnomAD4 genome AF: 0.0280 AC: 4265AN: 152294Hom.: 97 Cov.: 33 AF XY: 0.0269 AC XY: 2004AN XY: 74458
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
not specified Benign:1
- -
Cone-rod dystrophy 6;C2931258:Leber congenital amaurosis 1 Benign:1
- -
GUCY2D-related recessive retinopathy Benign:1
The variant NM_000180.4(GUCY2D):c.3044-7G>T is located in intron 16. This variant is present in gnomAD v.4.1.0 at a Grpmax allele frequency of 0.04452, with 52,788 alleles / 1,177,142 total alleles in the European (non-Finnish) population, which is higher than the ClinGen LCA / eoRD VCEP BA1 threshold of >0.016 (BA1). This variant has been found in the homozygous state in >6 adult individuals in gnomAD (1363 individuals, gnomAD version 4.1.0; BS2). In addition, the splicing impact predictor SpliceAI gives a delta score of 0.04, which is below the ClinGen LCA / eoRD VCEP recommended threshold of ≥0.2 and does not strongly predict an impact on splicing (BP4). In summary, this variant meets the criteria to be classified as Benign for GUCY2D-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: BA1, BP4. (VCEP specifications version 1.0.0; date of approval 01/22/2025). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at